This Scientist Stands To Make Billions With Custom Gene-Editing Tools
Benjamin Oakes Scribe Therapeutics is developing specialized Crispr proteins for multiple diseases–and it’s got deals with Big Pharma potentially worth over $4 billion
Source: forbes.com